Gastro esophageal reflux disease in pediatrics

Abstract

Gastro Esophageal Reflux (GER) is the passage of gastric content to the esophagus with or without vomitus or regurgitation. GER is a physiological process that occurs in 50% of newborns, spontaneously resolving at 12 to 14 months of age. When this retrograde gastric content reaches the esophagus and produces uncomfortable symptoms or complications, a disease is produced, named Gastro Esophageal Reflux Disease or GERD. Reflux episodes occur due to transient relaxation of the inferior esophagic sphincter, triggered by distension of the gastric fundus. Nursing children show higher frequency of episodes of relaxation due to a higher frequency of feeding than older children do. Most frequent symptoms include frequent regurgitation, with out without vomit, weight loss or poor weight gain, irritability, pyrosis, hematemesis, dysphagia, odinophagia, sibillances, stridor, cough, dysphonia, among others. These are very inespecific symptoms. Studies for GERD include 24 H pHmeasurement, which permits the study of associatrion between one of these symptoms and reflux, as well as the study of those patients with poor response to medical treatment. Unfortunately, it does not detect non-acid reflux. Multichannel intraluminal pH impedance measurement is a relatively new exam that measures the movement of fluids, gas or solids by a change in electric impedance through the esophagus. It allows to detect small volumes, type of content, acid and non acid and correlated with symptoms of GERD. Other useful exams include endoscopy with biopsy of the esophagus for diagnosis of esophagitis, esophageal mannometry for specific cases and gastroesophagic scintigram for pulmonary aspiration. Treatment include change in lifestyle (feeding, position, habits), pharmacological treatment and surgery. Medical treatment includes antacids, PPIs, most frequently omeprazole, H2 blockers such as ranitidine have a lower rate of healing of esophagitis than omeprazole, and appears to show tachyphylaxis after 6 weeks of treatment. Antireflux surgery has very specific indications, shows morbidity and mortality, and recurrence of symptoms.